GSK
4 years ago ⋅ English ⋅ 4 min read
Newsroom
GSK delivers strong Q2 sales of £8.1 billion, +6% AER, +15% CER Total EPS 27.9p -39% AER, -28% CER; Adjusted EPS 28.1p +46% AER +71% CER

For media and investors onlyFull results announcement (PDF)Download the Q2 2021 results announcementQ2 2021 results announcement (PDF, 1.2MB)Sales growth driven by strong commercial exe... Read More
GSK
4 years ago ⋅ English ⋅ 10 min read
Newsroom
GSK and Vir Biotechnology announce Joint Procurement Agreement with European Commission for COVID-19 treatment, sotrovimab

For media and investors onlyIssued: London UK and San Francisco, USGlaxoSmithKline plc and Vir Biotechnology, Inc. today announced they have signed a Joint Procurement Agreement with th... Read More
GSK
4 years ago ⋅ English ⋅ 6 min read
Newsroom
Shingrix approved in the US for prevention of shingles in immunocompromised adults

For media and investors onlyIssued: Philadelphia, LondonGlaxoSmithKline plc today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombin... Read More
GSK
4 years ago ⋅ English ⋅ 3 min read
Newsroom
Brian McNamara appointed CEO Designate of new independent Consumer Healthcare company

For media and investors onlyThe Board of GSK (GSK) today announces that Brian McNamara, the CEO of GSK Consumer Healthcare (a Joint Venture between GSK and Pfizer) has been appointed as... Read More
GSK
4 years ago ⋅ English ⋅ 9 min read
Newsroom
ViiV Healthcare presents data from second Dovato (dolutegravir/lamivudine) switch study confirming non-inferior efficacy and no virologic failure versus a broad range of regimens of at least 3 drugs

For media and investors onlyThe 48-week data from the phase III SALSA study represent a diverse patient population, and demonstrate comparable safety for 2-drug regimen Dovato versus co... Read More
GSK
4 years ago ⋅ English ⋅ 12 min read
Newsroom
ViiV Healthcare study shows new long-acting HIV regimen Cabenuva (cabotegravir/rilpivirine) can be successfully implemented in broad range of US healthcare practices, even during COVID-19

For media and investors only- Healthcare teams from a wide variety of US HIV clinics reported that optimal implementation of long-acting cabotegravir and rilpivirine dosed monthly was a... Read More